Patent details

EP3539982 Title: ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR

Basic Information

Publication number:
EP3539982
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP191607225
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR
French Title of Invention:
RÉGIONS CONSTANTES D'ANTICORPS MODIFIÉS POUR CONJUGAISON SPÉCIFIQUE À UN SITE, ET LEURS PROCÉDÉS ET UTILISATIONS
German Title of Invention:
KONSTANTE REGIONEN GENTECHNISCH HERGESTELLTER ANTIKÖRPER FÜR STELLENSPEZIFISCHE KONJUGATION SOWIE VERFAHREN UND VERWENDUNGEN DAFÜR
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
18/03/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
15/04/2025
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
19/02/2025
Unitary Effect Registration Date:
15/04/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
19/12/2012
Grant date:
19/02/2025
EP Publication Date:
18/09/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/02/2025
EP B1 Publication Date:
19/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/02/2025
 
 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

1

Name:
TUMEY, L. Nathan
Address:
United States (US)

2

Name:
BENNETT, Eric
Address:
United States (US)

3

Name:
TCHISTIAKOVA, Lioudmila
Address:
United States (US)

4

Name:
MARQUETTE, Kimberly
Address:
United States (US)

5

Name:
BIKKER, Jack
Address:
United States (US)

6

Name:
CALABRO, Valerie
Address:
France (FR)

7

Name:
GRAZIANI, Edmund
Address:
United States (US)

Priority

Priority Number:
201161580169 P
Priority Date:
23/12/2011
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/00; C07K 16/30;

Publication

European Patent Bulletin

1

Issue number:
202508
Publication date:
19/02/2025
Description:
Grant (B1)

2

Issue number:
202517
Publication date:
23/04/2025
Description:
Unitary Effect Request Receipt

3

Issue number:
202520
Publication date:
14/05/2025
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages